Infermedica 2020: Year in review
Infermedica navigated through 2020 and despite all obstacles, we kept supporting global healthcare to bring better health services. See what we achieved.
How COVID-19 symptom checkers remade the user paths
COVID-19 symptom checkers were a small and yet important step towards the digitization of healthcare. Let's see reshaped patient paths.
How symptom checkers are helping us deal with the pandemic
Although symptom checkers are not diagnosing nor curing coronavirus, they have turned out to be a great support in the fight against the pandemic.
Specialist Recommender is now available
Meet our new tool that adds recommendations of the physician and communication channel, to our pre-diagnosis processes.
Microsoft's bot to aid global healthcare
Microsoft has empowered multiple healthcare organizations with a fast and accurate pre-diagnosis tool. See how it uses Intermedia API.
Regression testing in validation of medical content
See how we use regression testing to investigate and improve the Infermedica database, which interlinks hundreds of symptoms and conditions.
Diagnostikare, end-to-end digital health services for enterprises
See how Infermedica API is used in Diagnostikare, a Mexican digital platform offering health services for patients and enterprises.
Areas to check before launching a healthcare app on Infermedica API
Everything you should know and double-check before launching the new healthcare application based on Infermedica API.
The multi-step clinical validation process at Infermedica
Validation is a vital part of creating medical content at Infermedica. See our testing methods and ways to improve the medical knowledge base.
Building a quality digital medical knowledge base
Our medical information base lies at the very heart of Infermedica solutions. We present 6 things that are the key to its quality and accuracy.
Sana Kliniken AG implements symptom checker
We formed a partnership with Sana Kliniken, one of the largest German healthcare providers.
Infermedica closes Series A funding with $10.25M
We are entering the next stage of growth. See how the new funds will accelerate the development of our AI-based solutions for healthcare.